Who manufactures Soliqua?

PARIS, Jan. 4, 2017 /PRNewswire-USNewswire/ — Sanofi announced today that Soliqua™ 100/33 (insulin glargine 100 Units/mL & lixisenatide* 33 mcg/mL injection) is now available by prescription in U.S. pharmacies.

Is Soliqua a glp1?

Soliqua is a combination of a long-acting human insulin analog with a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (1).

Who makes albiglutide?

Tanzeum (albiglutide), developed by GlaxoSmithKline (GSK), is a GLP-1 receptor agonist indicated for treatment of type 2 diabetes.

Is Soliqua fast acting?

Soliqua 100/33 contains a combination of insulin glargine and lixisenatide. Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Insulin glargine is a long-acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours.

Is there a generic for Soliqua?

There is currently no generic for Soliqua (insulin glargine / lixisenatide), so it can be expensive, even with insurance. GoodRx coupons, copay cards and patient assistance programs may help lower the cost.

What is GLP-1 medication?

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a group of drugs used to treat type 2 diabetes. GLP-1 RAs are very effective at lowering blood sugar levels.

Can GLP-1 and insulin be used together?

Basal insulin can be added to a GLP-1 receptor agonist with a slow titration to target goal fasting plasma glucose. In patients starting a GLP-1 receptor agonist, the dose of basal insulin should be decreased by 20 % in patients with an HbA1c ≤8 %.

Can you take metformin with Soliqua?

Soliqua (insulin glargine / lixisenatide) can be taken with other oral diabetes medications, like metformin (Glucophage), if your blood sugar level needs better control. Talk to your provider about your diabetes treatment and what medications may be right for you.